5-170108446-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_012188.5(FOXI1):āc.972G>Cā(p.Pro324Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0162 in 1,602,972 control chromosomes in the GnomAD database, including 267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.012 ( 15 hom., cov: 33)
Exomes š: 0.017 ( 252 hom. )
Consequence
FOXI1
NM_012188.5 synonymous
NM_012188.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.58
Genes affected
FOXI1 (HGNC:3815): (forkhead box I1) This gene belongs to the forkhead family of transcription factors, which is characterized by a distinct forkhead domain. This gene may play an important role in the development of the cochlea and vestibulum, as well as in embryogenesis. The encoded protein has been found to be required for the transcription of four subunits of a proton pump found in the inner ear, the kidney, and the epididymis. Mutations in this gene have been associated with deafness, autosomal recessive 4. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 5-170108446-G-C is Benign according to our data. Variant chr5-170108446-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 352710.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=3}. Variant chr5-170108446-G-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.58 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.012 (1829/152274) while in subpopulation NFE AF= 0.019 (1291/68016). AF 95% confidence interval is 0.0181. There are 15 homozygotes in gnomad4. There are 864 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXI1 | NM_012188.5 | c.972G>C | p.Pro324Pro | synonymous_variant | 2/2 | ENST00000306268.8 | NP_036320.2 | |
FOXI1 | NM_144769.4 | c.687G>C | p.Pro229Pro | synonymous_variant | 2/2 | NP_658982.1 | ||
FOXI1 | XR_941092.2 | n.1178G>C | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXI1 | ENST00000306268.8 | c.972G>C | p.Pro324Pro | synonymous_variant | 2/2 | 1 | NM_012188.5 | ENSP00000304286.5 | ||
FOXI1 | ENST00000449804.4 | c.687G>C | p.Pro229Pro | synonymous_variant | 2/2 | 1 | ENSP00000415483.2 |
Frequencies
GnomAD3 genomes AF: 0.0120 AC: 1829AN: 152156Hom.: 15 Cov.: 33
GnomAD3 genomes
AF:
AC:
1829
AN:
152156
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0122 AC: 3001AN: 245174Hom.: 27 AF XY: 0.0122 AC XY: 1614AN XY: 132330
GnomAD3 exomes
AF:
AC:
3001
AN:
245174
Hom.:
AF XY:
AC XY:
1614
AN XY:
132330
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0167 AC: 24165AN: 1450698Hom.: 252 Cov.: 34 AF XY: 0.0162 AC XY: 11683AN XY: 719742
GnomAD4 exome
AF:
AC:
24165
AN:
1450698
Hom.:
Cov.:
34
AF XY:
AC XY:
11683
AN XY:
719742
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0120 AC: 1829AN: 152274Hom.: 15 Cov.: 33 AF XY: 0.0116 AC XY: 864AN XY: 74440
GnomAD4 genome
AF:
AC:
1829
AN:
152274
Hom.:
Cov.:
33
AF XY:
AC XY:
864
AN XY:
74440
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 31, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 14, 2020 | - - |
Autosomal recessive nonsyndromic hearing loss 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at